<DOC>
	<DOCNO>NCT01102751</DOCNO>
	<brief_summary>We aim determine effect vitamin D replacement therapy serum FGF-23 concentration vitamin D deficient woman compare FGF-23 concentration vitamin D deficient patient healthy subject patient genetically-determined hypophosphatemic rickets .</brief_summary>
	<brief_title>Serum FGF-23 Vitamin D Deficiency</brief_title>
	<detailed_description>Study group compose vitamin D deficient female ( n =18 , mean age 29.1±9.9 yr ) , vitamin D sufficient healthy female ( control group ; n = 19 , mean age 28.5±5.2 yr ) patient genetically-determined hypophosphatemic rickets ( n=13 , mean age 26.5±15.1 yr ) . Groups compare serum FGF-23 , 1,25 dihydroxy vitamin D3 , calcium , phosphate , bone turnover marker , intact parathyroid hormone urinary excretion calcium phosphate . Vitamin D deficient group re-evaluated standard treatment regimen .</detailed_description>
	<mesh_term>Osteomalacia</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<criteria>Serum 25OHD Vitamin &lt; 30 ng/mL group 1 Serum 25OHD Vitamin &gt; 30 ng/mL control group Receiving medication ( ) affect bone metabolism History gastrointestinal disease malabsorption History renal liver disease</criteria>
	<gender>All</gender>
	<minimum_age>9 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>fibroblast growth factor 23</keyword>
	<keyword>Osteomalacia</keyword>
	<keyword>vitamin D</keyword>
</DOC>